308 related articles for article (PubMed ID: 35146577)
1. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Weber M; Lam M; Chiesa C; Konijnenberg M; Cremonesi M; Flamen P; Gnesin S; Bodei L; Kracmerova T; Luster M; Garin E; Herrmann K
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1682-1699. PubMed ID: 35146577
[TBL] [Abstract][Full Text] [Related]
2. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
[TBL] [Abstract][Full Text] [Related]
3. International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.
Veit-Haibach P; Ahlström H; Boellaard R; Delgado Bolton RC; Hesse S; Hope T; Huellner MW; Iagaru A; Johnson GB; Kjaer A; Law I; Metser U; Quick HH; Sattler B; Umutlu L; Zaharchuk G; Herrmann K
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3513-3537. PubMed ID: 37624384
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.
Lauri C; Signore A; Glaudemans AWJM; Treglia G; Gheysens O; Slart RHJA; Iezzi R; Prakken NHJ; Debus ES; Honig S; Lejay A; Chakfé N
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3430-3451. PubMed ID: 35376992
[TBL] [Abstract][Full Text] [Related]
5. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric
Vali R; Alessio A; Balza R; Borgwardt L; Bar-Sever Z; Czachowski M; Jehanno N; Kurch L; Pandit-Taskar N; Parisi M; Piccardo A; Seghers V; Shulkin BL; Zucchetta P; Lim R
J Nucl Med; 2021 Jan; 62(1):99-110. PubMed ID: 33334912
[TBL] [Abstract][Full Text] [Related]
6. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Giammarile F; Bodei L; Chiesa C; Flux G; Forrer F; Kraeber-Bodere F; Brans B; Lambert B; Konijnenberg M; Borson-Chazot F; Tennvall J; Luster M;
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1393-406. PubMed ID: 21494856
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France.
Garin E; Pinaquy JB; Bailly C; Sengel C; Mariano-Goulart D; Edeline J; Blanc JF; Bouvier A; Tordo J; Rode A; Becker S; Sefrioui D; de Baere T; Somma C; Mastier C; Goupil J; Chevallier P; Regnault H; Vibert E; Manfredi S; Vicaut E; Patel B; Boucher E; Guiu B;
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):1-11. PubMed ID: 34796373
[TBL] [Abstract][Full Text] [Related]
8. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
Wang EA; Stein JP; Bellavia RJ; Broadwell SR
Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
[TBL] [Abstract][Full Text] [Related]
9. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
[TBL] [Abstract][Full Text] [Related]
10. Locoregional therapy for hepatocellular carcinoma: radioembolization with yttrium-90 microspheres.
Herzer K; Müller S; Antoch G; Hilgard P
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):287-98. PubMed ID: 21769078
[TBL] [Abstract][Full Text] [Related]
11. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma.
Filippi L; Schillaci O; Cianni R; Bagni O
Future Oncol; 2018 Apr; 14(9):809-818. PubMed ID: 29251517
[TBL] [Abstract][Full Text] [Related]
13. Yttrium 90 microspheres for the treatment of hepatocellular carcinoma.
Memon K; Lewandowski RJ; Riaz A; Salem R
Recent Results Cancer Res; 2013; 190():207-24. PubMed ID: 22941023
[TBL] [Abstract][Full Text] [Related]
14. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres.
Haug AR; Heinemann V; Bruns CJ; Hoffmann R; Jakobs T; Bartenstein P; Hacker M
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1037-45. PubMed ID: 21308371
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Radioembolization (TARE) Agents beyond
Bouvry C; Palard X; Edeline J; Ardisson V; Loyer P; Garin E; Lepareur N
Biomed Res Int; 2018; 2018():1435302. PubMed ID: 30687734
[TBL] [Abstract][Full Text] [Related]
17. Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.
Al-Adra DP; Gill RS; Axford SJ; Shi X; Kneteman N; Liau SS
Eur J Surg Oncol; 2015 Jan; 41(1):120-7. PubMed ID: 25449754
[TBL] [Abstract][Full Text] [Related]
18.
Nezami N; Kokabi N; Camacho JC; Schuster DM; Xing M; Kim HS
Nucl Med Biol; 2018 Apr; 59():22-28. PubMed ID: 29448165
[TBL] [Abstract][Full Text] [Related]
19. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
Yu Q; Patel M; Kwak D; Ungchusri E; Wang Y; Van Ha T; Zangan S; Marshall E; Little K; Baker T; Liao CY; Pillai A; Ahmed O
J Vasc Interv Radiol; 2023 Nov; 34(11):1970-1976.e1. PubMed ID: 37532096
[TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
Allison C
Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
